Gilead Sciences | Nettoeinkommen



Net Income Veränderung Datum
AbbVie USD 1.29B 1.31B 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
ALKERMES USD 87.1M 64.63M 2025-06
Alnylam Pharmaceuticals USD -66277000 8.8M 2025-06
Amgen USD 1.73B 1.1B 2025-03
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.44B 181M 2025-06
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 405M 246.8M 2025-06
J&J USD 5.54B 5.46B 2025-06
Merck USD 4.43B 652M 2025-06
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Novartis USD 4.02B 418M 2025-06
Pfizer USD 2.97B 2.56B 2025-03
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Sanofi EUR 1.87B 1.37B 2025-03
Sarepta Therapeutics USD -447508000 606.56M 2025-03
United Therapeutics USD 309.5M 12.7M 2025-06
Vertex Pharmaceuticals USD 913M 132.4M 2024-12


Gilead Sciences Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.